<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04313140</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02531-56</org_study_id>
    <nct_id>NCT04313140</nct_id>
  </id_info>
  <brief_title>Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging</brief_title>
  <official_title>Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO&#xD;
      ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before&#xD;
      any medical decision. Currently, only anatomical biopsy can give the tumor grade definition&#xD;
      and help to define the most adapted treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">June 2026</completion_date>
  <primary_completion_date type="Anticipated">June 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of the virtual biopsy in the context of gliomas through the use of statistical learning algorithms (artificial intelligence) compared to the biopsy.</measure>
    <time_frame>The MRI examination (for 2 hours 30 minutes)</time_frame>
    <description>Evaluate the diagnostic capabilities of artificial intelligence algorithms for virtual biopsy based on sensitivity and specificity</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Development of the Virtual Biopsy</condition>
  <condition>Tumor Grade</condition>
  <condition>Artificial Intelligence Algorithms</condition>
  <condition>Clinical</condition>
  <condition>Radiological</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Diagnostic test</intervention_name>
    <description>The intervention occurs only one time (for 2h30), the MRI examination is divided as follow:&#xD;
Cinicial MRI (50 minutes)&#xD;
Research MRI (Phosphorus Spectroscopy, Sodium Imaging)</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age≥ 18 years,&#xD;
&#xD;
          -  Patient with suspected glioma with prior imaging&#xD;
&#xD;
          -  Subject free, with legal protection guardianship or curatorship;&#xD;
&#xD;
          -  Enrollment in the French Social Security system;&#xD;
&#xD;
          -  Informed consent signed by the patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any contraindication to an MRI examination&#xD;
&#xD;
          -  Legal protection, namely minors, persons deprived of their liberty by a judicial or&#xD;
             administrative decision, persons residing in a health or social establishment, adults&#xD;
             under legal protection and finally patients in emergency situations&#xD;
&#xD;
          -  Pregnant or lactating women, women of childbearing age who do not have effective&#xD;
             contraception&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rémy GUILLEVIN, Pr</last_name>
    <phone>05.49.44.45.42</phone>
    <email>remy.guillevin@chu-poitiers.fr</email>
  </overall_contact>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 16, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

